Pneumococcal 13-Valent Vaccine Dosage

The information at Drugs.com is not a substitute for medical advice. ALWAYS consult your doctor or pharmacist.

Usual Adult Dose for:

Usual Pediatric Dose for:

Additional dosage information:

Usual Adult Dose for Pneumococcal Disease Prophylaxis

50 years and older: 0.5 mL IM (a single dose).

Usual Pediatric Dose for Pneumococcal Disease Prophylaxis

Infants (6 weeks to 6 months):
0.5 mL intramuscular injection administered at 2, 4, 6, and 12 to 15 months of age for 4 total doses; the first dose may be given as young as 6 weeks of age, but is typically given at 8 weeks (2 months of age); the 3 remaining doses are usually given at 4, 6, and 12 to 15 months of age. The recommended dosing interval is 4 to 8 weeks. The minimum interval between doses in children less than year of age is 4 weeks. The minimum interval between the third and fourth dose is 8 weeks.
Infants 7 to 11 months: 0.5 mL for 3 total doses; 2 doses at least 4 weeks apart, followed by a third dose at 12 to 15 months, separated from second dose by at least 8 weeks.
Children 12 to 23 months: 0.5 mL for 2 total doses, at least 8 weeks apart.
Children 24 to 59 months: Healthy children: 0.5 mL as a single dose.
Children 24 to 71 months with underlying medical conditions: ACIP recommendations: 0.5 mL for a total of 2 doses, separated by 8 weeks.

Previously vaccinated with pneumococcal 7 valent and/or pneumococcal 13 valent with a lapse in administration (ACIP recommendations):
Infants 7 to 11 months and previously received 1 or 2 doses: 0.5 mL dose at 7 to 11 months of age, followed by a second dose at least 8 weeks later at 12 to 15 months of age.
Children 12 to 23 months:
Previously received 1 dose before 12 months of age: 0.5 mL dose, followed by a second dose at least 8 weeks later.
Previously received 1 dose at 12 months of age or older: 0.5 mL dose at least 8 weeks after the most recent dose.
Previously received 2 or 3 doses before age 12 months: 0.5 mL dose at least 8 weeks after the most recent dose.
Children 24 to 59 months (healthy children with any incomplete schedule): 0.5 mL dose at least 8 weeks after the most recent dose.
Children 24 to 71 months with an underlying medical condition:
Previously received less than 3 doses: 0.5 mL dose at least 8 weeks after the most recent dose, followed by a second dose at least 8 weeks later.
Previously received 3 doses: 0.5 mL as a single dose at least 8 weeks after the most recent dose.
Previously completed vaccination series with pneumococcal 7 valent (4 doses) (ACIP recommendations):
Children 14 to 59 months: 0.5 mL as a single supplemental dose at least 8 weeks after the most recent dose.
Children 24 to 71 months with an underlying medical condition: 0.5 mL as a single supplemental dose at least 8 weeks after the most recent dose of pneumococcal 7 valent or pneumococcal 13 valent .
High risk for invasive pneumococcal disease (ACIP recommendations): Children 6 to 18 years: 0.5 mL as a single dose at least 8 weeks after the most recent dose of pneumococcal 7 valent or pneumococcal 13 valent (if applicable).

Renal Dose Adjustments

Data not available

Liver Dose Adjustments

Data not available

Dialysis

Data not available

Other Comments

Preterm infants should be vaccinated according to their chronological age from birth.

Hide
(web1)